Medical Xpress November 29, 2024
An international research team including researchers from Augsburg University Medicine has made significant progress in the risk assessment and treatment of extracranial malign rhabdoid tumors. Recently published in the journal Clinical Cancer Research, the study, “Clinical and Molecular Risk Factors in Extracranial Malignant Rhabdoid Tumors: Toward an Integrated Model of High-Risk Tumors,” shows how clinical and molecular factors can influence disease progression and contribute to improvements in individual treatment.
Malign rhabdoid tumors are rare and affect around 35 children a year in Germany, in particular infants and toddlers. Due to the aggressive nature of the disease and the high rate of recurrence in this type of cancer, treatment is often difficult.
As there has been no established model of prognosis...
Today's Sponsors
Today's Sponsor